Medication Shield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share French medication intelligence company Synapse Medicine has rolled-out its Medication Shield technology in collaboration with the regional pharmacovigilance centers (CRPVs) and the French National Agency for Medicines and Health Products Safety (ANSM). The technology claims to increase the safety of the COVID-19 vaccination campaign in France by managing the adverse drug reactions (ADRs) signals on a reporting portal, which is implemented by the French Ministry of Health. The reactions are encoded automatically into a standardised international terminology (MedDRA) which ranks them ...

Share this article Share this article BORDEAUX, France, Jan. 15, 2021 /PRNewswire/ -- Synapse Medicine, which was founded by public health physicians, rolls out its Medication Shield technology to increase the safety of the COVID-19 vaccination campaign in France, in collaboration with the regional pharmacovigilance centers (CRPVs) and the French National Agency for Medicines and Health Products Safety (ANSM). This technology comes out as a valuable time-saver, supporting the management of adverse drug reaction (ADR) reports by making it easier and allowing pharmacovigilance teams to focus th...